Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D.

Glycemic management is central in prevention of small vessel and cardiovascular complications in type 2 diabetes. With the plethora of newer medications and recommendations for a patient centered approach, more information is necessary to match the proper drug to each patient. We showed that BARI 2D, a five-year trial designed to compare two different glycemic treatment strategies, was suitable for assessing different responses according to different phenotypic characteristics.

Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study.

Objectives: To demonstrate that pharmacists working with physicians and other providers in an ambulatory care setting can improve glucose, blood pressure, and lipid control for patients with type 2 diabetes and to report patient adherence to screening and general preventive measures.

Design: Prospective, randomized, clinical practice study.

Setting: Burlington, MA, between January 2001 and August 2003.

Subclinical hypothyroidism.

Preview What causes subclinical hypothyroidism? How prevalent is it? When is it likely to progress to overt disease? Are clinical abnormalities sometimes present? Answers to these questions, as well as a discussion of treatment approaches, are found in this overview.